OSAIC HOLDINGS, INC. - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 79 filers reported holding HUMACYTE INC in Q2 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$116,015
+19.4%
39,600
+16.5%
0.00%
Q2 2023$97,203
+7.5%
33,985
+16.3%
0.00%
Q1 2023$90,414
+55.9%
29,210
+5.3%
0.00%
Q4 2022$58,000
-34.1%
27,729
+3.1%
0.00%
Q3 2022$88,000
+2.3%
26,904
+0.2%
0.00%
Q2 2022$86,000
-51.4%
26,854
+7.3%
0.00%
Q1 2022$177,000
+21.2%
25,020
+24.6%
0.00%
Q4 2021$146,000
-30.8%
20,074
+10.2%
0.00%
Q3 2021$211,00018,2240.00%
Other shareholders
HUMACYTE INC shareholders Q2 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders